LP268226-0
Vortioxetine
Active
Description
Vortioxetine is an antidepressant used to treat major depressive disorder (MDD). It binds to a variety of serotonin receptors and also inhibits the reuptake of serotonin, thereby increasing the amount of 5-HT in the synapse. Vortioxetine may also help reduce symptoms of anxiety. PMID: 25851751 Vortioxetine takes about 2 weeks to reach steady-state concentration in the plasma, and it is primarily metabolized in the liver to an inactive metabolite. Side effects are primarily self-limited and include nausea, headache, and abdominal pain. PMID: 29920978 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Vortioxetine
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2018-07-27
- Construct for LOINC Short Name
- Vortioxetine
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP268226-0 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP268226-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Vortioxetina |
| it-IT | Italian (Italy) | Vortioxetina |
| zh-CN | Chinese (China) | 沃替西汀 Synonyms: 伏硫西汀; |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright